M&A-minded Piramal near $500M deal to sell pharma stake to KKR: report
admin 29th April 2020 Uncategorised 0Indian contract manufacturer and generics maker Piramal has invested millions in recent years to boost production of high-potency pharmaceutical ingredients at its Michigan plant and abroad. Now, an outside investor could help Piramal on its quest to keep growing through major acquisitions.
More: M&A-minded Piramal near 0M deal to sell pharma stake to KKR: report
Source: fierce